2020
DOI: 10.1016/j.ica.2020.119824
|View full text |Cite
|
Sign up to set email alerts
|

DNA binding, cleavage, apoptosis and cytotoxicity studies of three heteroleptic nickel complexes bearing β-diketones

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
3
0
1

Year Published

2021
2021
2025
2025

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 25 publications
(4 citation statements)
references
References 49 publications
0
3
0
1
Order By: Relevance
“…Structures assembled in Cu 2+ and Ni + showed a smear, indicating potential DNA cleavage reported earlier in these ions. [44,45] We then used AFM to visually examine the formation of the DNA origami triangle in the conditions that showed proper assembly on agarose gels. AFM analysis confirmed proper assembly of the DNA origami triangle in 10 mm Ca 2+ and Ba 2+ ions compared to the control structures assembled in 10 mm Mg 2+ (Figure 3d).…”
Section: Assembly Of a Dna Origami Trianglementioning
confidence: 99%
“…Structures assembled in Cu 2+ and Ni + showed a smear, indicating potential DNA cleavage reported earlier in these ions. [44,45] We then used AFM to visually examine the formation of the DNA origami triangle in the conditions that showed proper assembly on agarose gels. AFM analysis confirmed proper assembly of the DNA origami triangle in 10 mm Ca 2+ and Ba 2+ ions compared to the control structures assembled in 10 mm Mg 2+ (Figure 3d).…”
Section: Assembly Of a Dna Origami Trianglementioning
confidence: 99%
“…In this respect and since nickel lies in the same group as platinum, fundamental strategies to design pharmaceuticals based on Ni( ii ) complexes have become a pivotal area of research. 9–12 Ni( ii ) complexes are regarded as one of the most promising alternatives to the traditional cisplatin as an anticancer drug, an idea supported by a considerable number of research articles describing the synthesis, DNA binding, and cytotoxic activities of these complexes. 13 Earlier experimental studies with calf thymus DNA have shown that Ni complexes have a very high potential to be used as DNA inhibitors.…”
Section: Introductionmentioning
confidence: 99%
“…Among non-platinum based compounds, in 1995, Hanauske and coworkers introduced budotitane as the first titanium(IV) drug for cancer treatment [10]. Other cytotoxic β-dicarbonyls exploit the presence of Ru II [11], Co II [12], Cu II [13,14], Ni II [15,16] and oxovanadium(IV) [17].…”
Section: Introductionmentioning
confidence: 99%